Pacira Biosciences, Inc. PCRX
NASDAQ · United States · Health Technology
$25.12+0.07 (+0.28%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 0.73 | 0.65 | +13.0% | $192.40M | +0.7% | -7.6%$26.92→$24.87 |
| Q1 2026 | 2026-04-30 | 0.34 | 0.33 | +3.0% | — | — | -2.8%$25.14→$24.44 |
| Q4 2025 | 2026-02-26 | 0.32 | 0.60 | -46.7% | — | — | -6.6%$23.46→$21.91 |
| Q3 2025 | 2025-11-06 | 0.46 | 0.42 | +9.5% | — | — | +0.9%$21.85→$22.05 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.